NextDecade Q2 2026 Earnings Preview (NASDAQ:NEXT)
Track NextDecade (NEXT) Q2 earnings on July 30 before the open: consensus EPS -$0.50 with 1 upward revision in 3 months.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Track NextDecade (NEXT) Q2 earnings on July 30 before the open: consensus EPS -$0.50 with 1 upward revision in 3 months.
NextDecade Q2 2026 Earnings Preview (NASDAQ:NEXT) | Seeking Alpha
NextDecade (
NEXT
) is scheduled to announce Q2 earnings results on Thursday, July 30th, before market open.
The consensus
EPS Estimate is -$0.50
.
Over the last 3 months, EPS estimates have seen 1
upward revision
and 0 downward.
More on NextDecade
NextDecade: The LNG Upside Is Worth The Risk
NextDecade Corporation (NEXT) Q1 2026 Earnings Call Transcript
NextDecade Corporation 2026 Q1 - Results - Earnings Call Presentation
Excelerate Energy rated new Buy, NextDecade Neutral at Goldman Sachs
NextDecade's Rio Grande LNG prices $3.5B secured notes
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Markel Q2 Results: Insurance Underwriting and Investment Drive Steady Growth
Markel reported solid Q2 results with improved combined ratio, robust investment returns, and continued expansion at Markel Ventures. This analysis dives into key highlights and industry challenges.
Axogen Targets 24% Revenue Growth to $279M by 2026: Breast Reconstruction Nerve Repair Accelerates, Driving MedTech Stock
Axogen issued a strong 2026 revenue guidance of at least $279 million, representing 24% growth, driven by accelerating adoption of its nerve repair products in breast reconstruction surgery. The company's strategic focus and market positioning are analyzed, along with investment risks.
Seven Hills Realty Trust targets $950M-$960M portfolio size while projecting Q3 distributable earnings of $0.23-$0.25 per share (NASDAQ:SEVN)
Seven Hills Realty Trust (SEVN) Q2 2026 earnings call recap: distributable earnings, dividend outlook, loan originations, CECL reserves & office exposure.
DT Midstream 2026 Q2 Earnings Preview: Natural Gas Demand Supports Performance, Market Focuses on CapEx Guidance
DT Midstream is set to release its Q2 2026 earnings. This article provides a forward-looking analysis of the natural gas midstream infrastructure company's performance and investment value, covering industry trends, key financial metrics, management outlook, and risk factors.
